Immunotherapies
have evolved
Harnessing more of the immune system for better cancer outcomes
Latest News

We hosted @jonatcoquet from KI today at @oNKo_innate and heard some fascinating insights into novel roles for Th2 cells in infection and cancer. Thanks for the stimulating visit Jonno 🙏

@Dr_Nick_Bikes @oNKo_innate Pleased to come and talk at onko! It was a great environment to speak in. Thanks for entertaining my random thoughts on Cd4s and cancer

Calling all post-doc level scientists wanting a career in industry with some of the best in immuno-oncology research:
http://careersaustralia.monash.edu/cw/en/job/644196/senior-research-scientist
We can't wait to meet you --> applications close December 11 🙏

Load More...
 
Discover oNKo-innate
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
Learn more
OUR APPROACH
Using powerful genomic approaches, we screen primary immune cells and cancer cells to understand their interaction within a tumor.
Learn more
lab1-webRes
o o
o
THE TEAM
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
Find out who we are